High versus low dose of initial thyroid hormone replacement for congenital hypothyroidism

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2009, Pages

  Ng, Sze May ^a   Anand, Dhullipala ^b   Weindling, Alan M ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b QUEEN MOTHER S HOSPITAL   (United Kingdom)

Author keywords

*Hormone replacement therapy; Congenital hypothyroidism *drug therapy ; Humans; Infant; Infant, newborn; Thyroxine *administration dosage

Indexed keywords

LEVOTHYROXINE; LIOTHYRONINE; THYROTROPIN; THYROXINE;

ATTENTION; CHILD BEHAVIOR; CHILDHOOD MORTALITY; CLINICAL TRIAL; COGNITIVE DEVELOPMENT; CONGENITAL HYPOTHYROIDISM; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; FREE THYROXINE INDEX; GROUPS BY AGE; HORMONE INHIBITION; HORMONE SUBSTITUTION; HUMAN; INTELLIGENCE; INTELLIGENCE QUOTIENT; LANGUAGE ABILITY; LIOTHYRONINE BLOOD LEVEL; LOADING DRUG DOSE; LOW DRUG DOSE; MEMORY; MENTAL FUNCTION; MENTAL PERFORMANCE; META ANALYSIS; MORBIDITY; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 70249138295     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006972.pub2     Document Type: Review

References (45)

1. Selva KA, Mandel SH, Rein L, Sesser D, Miyahira R, Skeels M, Nelson JC, La Franchi SH. Initial treatment dose of L-thyroxine in congenital hypothyroidism. J Peadiatr 2002;141:786-792 (Pubitemid 35471639)
2. Selva KA,Harper A, Downs A, Blasco PA, La Franchi SH. Neurodevelopmental outcomes in congenital hypothyroidism: comparison of initial T4 dose and time to reach target T4 and TSH . J Pediatr 2005;147:775-780 (Pubitemid 41774832)
3. Bongers-Schokking JJ, Koot HM, Wiersma D, Verkerk PH, de Muinck Keizer-Schrama SMPF. Influence of timing and dose of thyroid hormone replacement on development in infants with congenital hypothyroidism. Journal of Pediatrics 2000;136:292-297 (Pubitemid 30470949)
4. Bongers-Schokking JJ, deMuinck Keizer-Schrama SM. Influence of timing and dose of thyroid hormone replacement on mental, psychomotor, and behavioral development in children with congenital hypothyroidism. J Pediatr 2005;147:768-774
5. Campos SP, Sadberg DE, Barric C, Vorhess ML, Mcgillivary MH. Outcome of low dose initial thyroxine therapy for congenital hypothyroidism. Clinical Pediatrics 1995;34:514-520
6. Cassio A, Cacciari E, Cicognani A, Damiani G, Missiroli G, Corbelli E. Treatment for congenital hypothyroidism: thyroxine alone or thyroxine plus triiodothyronine?. Pediatrics 2003;111:1055-1060 (Pubitemid 36542621)
7. Chiesa A. Growth follow-up in 100 children with congenital hypothyroidism before and during treatment. The Journal of Pediatric Endocrinology and Metabolism 1994;7(3):211-217 (Pubitemid 24288939)
8. Dubuis J, Glorieux J, Richer F, Dussault JH, Vliet GV. Outcome of severe congenital hypothyroidism: closing the developmental gap with early high dose levothyroxine therapy. Journal of Clinical Endocrinology and Metabolism 1996;81:222-227 (Pubitemid 26035027)
9. Gunn AJ,WakeM,Cutfield WS.High and low dose initial thyroxine therapy for congenital hypothyroidism. J Paediatr Child Health 1996; 32:242-245
10. Salerno M, Militerni R, Bravaccio C, Micillo M, Capalbo D, Di MS, Tenore A. Effect of different starting doses of levothyroxine on growth and intellectual outcome at four years of age in congenital hypothyroidism. Thyroid 2002;12(1):45-52. [: 1050-7256 (Print)] (Pubitemid 34106716)
11. Schwartz ID, Turner K, Kruger T, Bennet D, Howard CP, Grunt JA. Neuropsychological outcome in children with congenital hypothyroidism treated with varying amounts of levothyroxine during first 2 years of life. International Pediatrics 1994;9:254-259
12. Simoneau-Roy J. Cognition and behavior at school entry in children with congenital hypothyroidism treated early with high-dose levothyroxine. J Pediatr 2004;144:747-752 (Pubitemid 38858091)
13. Touati G, Leger J, Toublanc JC. A thyroxine dose of 8 mg/kg per day is appropriate for initial treatment of the majority of infants with congenital hypothyroidism. Eur J Pediatr 1997;156:94-98 (Pubitemid 27049149)
14. Vanhole C, Aerssens P, Naulaers G, Casneuf A, Devlieger H, Van Den BG. L thyroxine treatment of preterm newborns: Clinical and endocrine effects. Pediatr Res 1997;8:87-92. (Pubitemid 27276763)
15. American Academy of Paediatrics. Newborn screening for congenital hypothyrodism: Recommended guidelines. Pediatrics 1993;91:1203-1209
16. Abusrewil SSA, Tyfield L, Savage DCL. Serum thyroxine and thyroid stimulating hormone concentrations after treatment of congenital hypothyroidism. Archives of Disease in Childhood 1988;63:1368-1371 (Pubitemid 18258774)
17. Bakker B, Kempers MJ, De Vijdler JJ. Dynamics of plasma concentrations of TSH, FT4 and T3 following thyroxine supplementation in congenital hypothyroidism. Clinical Endocrinology 2002;57:529-537 (Pubitemid 35216305)
18. Brown RS, Bellisaro RL, Botero D. Incidence of transient congenital hypothyroidism due to maternal thyrotropin receptor-blocking antibodies in over one million babies. Journal of Clinical Endocrnology and Metabolism 1996;81:1147-1151 (Pubitemid 26083984)
19. Calaciura F, Motto RM, Miscio G. Subclinical hypothyroidism in early childhood: a frequent outcome of transient neonatal hyperthyrotropinemia. Journal of Clinical Endocrinology and Metabolism 2002;87:3209-3214 (Pubitemid 34816367)
20. Cohen J. A coefficient of agreement for nominal scales. Educational and Psychological Measurement 1960;20:37-46.
21. Fisher DA, Foley TP. Early treatment of congenital hypothyroidism. Journal of Pediatrics 1989;117:211-219
22. Germak JA, Foley TP. Longitudinal assessment of L-thyroxine therapy for congenital hypothyroidism. Journal of Pediatrics 1990;117:211-219 (Pubitemid 20238532)
23. Grant DB, Smith I, Fuggle PW, Tokar S, Chapple J. Congenital hypothyroidism detected by neonatal screening: relationship between biochemical severity and early clinical features. Archives of Disease in Childhood 1992;67:87-90.
24. Gruters A, Jenner A, KrudeH. Long termconsequences of congenital hypothyroidism in the era of screening programmes. Best Practice Research Clinical Endocrinology and Metabolism 2002;16:369-382 (Pubitemid 35251980)
25. Haddow JE, Palomaki GE, Allan WC. Maternal thyroid function during pregnancy and subsequent neuropsychological development of the child. New England Journal of Medicine 1999;341:549-555 (Pubitemid 29384162)
26. Heyerdahl S, Kase BF, Lie SO. Intellectual development in children with congenital hypothyroidism in relation to recommended thyroxine treatment. Journal of Pediatrics 1991;118:850-857
27. Higgins JPT, Thompson SG. Quantifying heterogeneity in a metaanalysis. Statistics in medicine 2002;21:1539-1558
28. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency inmeta-analysis. BritishMedical Journal 2003;327:557-560
29. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. In: The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org..
30. Hulse JA. Outcome for congenital hypothyroidism. Archives of Disease in Childhood 1984;59:23-30.
31. Jones JH, Gellen G, Paterson WF, Beaton S, Donaldson MD. Effect of high versus low initial doses of L-thyroxine for congenital hypothyroidism on thyroid function and somatic growth. Arch Dis Child 2008;93(11):940-944
32. Jüni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001;323 (7303):42-46 (Pubitemid 32682008)
33. LaFranchi S. Thyroid function in the preterm infant. Thyroid 1999;9(1):71-8. [: 1050-7256 (Print)]
34. Lau J, Ioannidis JPA, Terrin N, Schmid CH, Olkin I. The case of the misleading funnel plot. BMJ 2006;333:597-600.
35. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports ofmeta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999;354(9193):1896- 1900
36. Murphy G, Hulse JA, Jackson D. Early treated hypothyroidism: development at 3 years. Archives of Disease in Childhood 1986;61:761-765 (Pubitemid 16033941)
37. Ng PC, Lee CH, Lam CW, Ma KC, Fok TF, Chan IH, Wong E. Transient adrenocortical insufficiency of prematurity and systemic hypotension in very low birthweight infants. Archives of Disease in Childhood Fetal Neonatal Ed 2004;89(2):F119-26. [: 1359-2998 (Print)]
38. Oerbeck B, Sundet K, Kase BF, Heyerdahl S. Congenital hypothyroidism: influence of disease severity and L-thyroxine treatment on intellectual, motor and school-associated outcomes in young adults. Pediatrics 2003;112:923-930 (Pubitemid 37248703)
39. Rovet JF, Ehrlich RM. Long term effects of L-thyroxine therapy for congenital hypothyrodism. Journal of Pediatrics 1995;126:380-386
40. Rovet JF. Congenital hypothyroidism: an analysis of persisting deficits and associated factors. Child Neuropsychology 2002;8:150-162
41. SalernoM,Militerni R,DiMaio S, BravaccioC,GaspariniN, Tenore A. Intellectual outcome at 12 years of age in congenital hypothyroidism. European Journal of Endocrinology 1999;141(2):105-10. [: 0804-4643 (Print)] (Pubitemid 29402211)
42. Simoneau-Roy J, Marti S, Deal C, huot C, Robaey P, Van Vliet G. Cognition and behaviour at school entry with children with congenital hypothyroidism treated early with high dose levothyroxine. J Pediatr 2004;144:747-752 (Pubitemid 38858091)
43. Song SI, Daneman D, Rovet J. The influence of etiology and treatment factors on intellectual outcome in congenital hypothyroidism. Journal of Developmental Behavioural Pediatrics 2001;22(6):376-384 [: 0196-206X (Print)] (Pubitemid 34026941)
44. Sterne JAC, EggerM, Davey Smith G. Investigating and dealing with publication and other biases. In: Egger M, Davey Smith G, Altman DG editor(s). Systematic Reviews in Health Care; Meta-analysis in Context. London: BMJ Publishing Group, 2001:189-208.
45. Working group on neonatal screening of the European Society of Paediatric Endocrinology. Revised guidelines for neonatal screening programmes for primary congenital hypothyroidism. Horm Res 1999;52:49-52.